for today conference XXXX you, us Heather. Rockwell and and quarter fourth full-year call morning, joining for results Medical's and thank you webcast. Good everyone, Thank
this with a number we want review to that have morning. We accomplishments you of exciting
let’s So, started. get
to a to Rockwell remind new of a a of you following revenue minutes is develops, those healthcare that who Rockwell hemodialysis like of Medical been dialysis and and you providers strategy. for who our model of take worldwide. distributes are commercializes, to have few manufacturers, portfolio company and Medical I’d those For us time, products business for for updated generating everyone some
transportation Rockwell’s is they by the dialysis supported highest has the dialysis products, along the the and with one scalability the manufacturing products dialysis in of provide concentrates and hemodialysis mission best the to United the suppliers clinics supplier States, infrastructure service over customer is service to markets. is select clinics Rockwell patients international that United in in only X,XXX with quality industry. States second serve largest of two life-sustaining the the in clinics
in expanding which the grow Rockwell approximately large player States as approximately valued in is and $XXX a indispensable positions and XXXX. market, in currently This United projected at to to million million alone $XXX an is
Our to vision providers of concentrates become dialysis the worldwide. hemodialysis global supplier leading to is
de-levering XXXX. evaluation successful, Rockwell's together July businesses, and us we be team Rockwell underwent that for board intensive improving and capital focus on our pause businesses, drive enhancing financial our our profitability in need our to revenue to generating focus condition, on company, efforts this assessment and and After directors Medical of extensive last Rockwell our in determined of with an I joining and of businesses year, management to
The revised these We focused key that objectives. is is goals XXXX the for and and working. full-year here third believe are for and business and gross operating profit are fourth takeaway making significant now is the progress quarter the second is towards Revenue results and our that quarter we reported expenses growing, that increasing, demonstrate we model and declining.
made we of In results. fourth our full-year to of turn the attention quarter and operational XXXX, to XXXX our operational number let's fourth a improvements business. Rockwell's Now, quarter
we reacquired point that critical into the agreement originally from products exclusive First, back and entered terminated concentrates for distribution Rockwell. to distribution a hemodialysis transaction Rockwell inflection marked Baxter our in rights our XXXX. This
the our our ourselves of of restrictive impossible long-term for from number preferred made Baxter economics. agreements to lifted first that agreement and us destiny. to time the business elements us allows it with supply to a Removing business this establish Re-acquisition grow control for own
transitioning the establishing and existing is opportunities new United customers progress commercial commercial provide to ahead actively Our Baxter will onboarding and dollar and with the States purchase, agreements. making are and Tim supply, product we lie you for Rockwell. in transition the more details and long-term business team on the Rockwell, multimillion the distribution abroad, with that
our Additionally, We development as the reduced fourth our overall top U.S., the non-core revenue, headcount eliminated operations. product G&A put areas expense. streamlined our and associated reduced decision cash business We line improve our made Triferic quarter, activities and our in to we on-hold. reduced platform the with of related burn, to to expenses this associated we in FPC and move strategic away from with the continued
develop had AVNU their South Triferic Triferic approved international Rockwell were partnerships In looking respective commercialize in companies the during third quarter. Korea our in and countries. Korea launched with GEO XXXX, and several Pharmaceutical South to partner in Triferic Triferic and
actively realize have license of are to associated and already supply keeping GEO's revenue agreements. and begun Triferic's track We with adoption market
X subsidiary XXXX in study a Pharma, partner its mid-XXXX. in of expect study from completed quarter we China, and pivotal Phase this In fourth in addition, the results our of Fosun
operational partnerships Rockwell. reminder, little require a capital from very no As expenditure and international these resources
While generate revenue this the to the have potential and not factored our long-term near have revenue forecasts. for they company, into we
the to come. work during would it expenditures Rockwell development program many this relates required significant capital quarter value put realize years for this FPC and for we we from that on-hold to announced of Infusion, XXXX because it not program fourth for As Home
activities consider with this FPC the at FDA as acute development for the meeting for heart of provided pre-IND future a conducted we which successful insight As XXXX, for useful end program. failure, the we
us Rockwell achieves is we and available discussed this sustainable As for reconsider once profitability. program previously, have is to currently on-hold
Before illustrates the our in release. objectives we more financials transition felt direct this transparent, against this impact our to take the our This way communicates we I progress format believe clearly get press are this that to per and results, presenting financials. and customary into we wanted our new updated straightforward manner, results our a in of moment evolved revenue our in successful presented on we time is and morning's the share. a earnings financial businesses to making measurement to and type it address format of which was financial We generating
million XXXX, third consecutive our pleased achieving which $XX.X we report company's I represented for record in that to revenue, fourth am the in the quarter revenue quarter reported history.
increase XXXX, For the period when and generated million revenue the represents Rockwell the compared full-year revenue highest full-year which to company. in in guidance, to comparable for the $XX.X XXXX a our date XX.X% exceeding
XXXX. XXXX interest quarter of XXXX, as a our opportunity only XXXX. our agreement of an interest the of last into payment down fourth September debt loan prepayment $XX with of X, by long-term existing Rockwell a December its accelerating XX, pay Medical loan entered with the on of amendment starting we our our debt leaving December period XX-month This of ending million expense with and million X, Rockwell to to During agreeing offers the reduce $X
with As plan with expanding by We preferred growing customers, agreements commercially look to our into focus are business geographies, on XXXX, adding supply economics. agreements we to clear. optimizing new our new with long-term objectives existing very corporate customers
focus We expect continue and expenses business to to our our operating on reducing efficiently. more
our to seek continue to At goals our $XX XX% top to ways to of further reduce this concentrates range, and hemodialysis XXXX, financial condition generate enhance find demand in in the $XX that XXXX. to Based million revenue for revenue on we million represents these over forecasted a increase to products ways plan in in our debt. We expect XXXX. and
million profit in are In company continue addition, achieve with have in gross business and generate million and expecting we profitability to XXXX. make $X XXXX stronger position. made forward stable decisions put financial to consistent a between we more to our $X drive in our strategy The to going are the and
fourth anticipate revenue renewals. of on will timing way of for well first are contract the the the the and transition of reflecting in-line be our in quarter Baxter We XXXX with in revenue that quarter XXXX,
renal would significantly XX largest years than who care Senior Vice commercial to President you Marketing in our to has introduce and experience had our renal Tim sales. world of leads Sales like successfully and and in more Tim of Rockwell. of companies portfolios Now, marketing the Chole, organization built some their I grown the sales and here at at care
turn with provide to Tim our update business. call commercial now will concentrates I related over a to to the hemodialysis you